As a progressive, irreversible neurodegenerative disease, Alzheimer's disease (AD)
continues to be a serious public health problem worldwide. Currently, the most available …

Increasing brain disease incidence has become a common cause of disability and death
worldwide. Early diagnosis of brain diseases is crucial to improve the prognosis of patients …

Dementia, most often associated with neurodegenerative diseases, affects millions of
people worldwide, predominantly the elderly. Unfortunately, no treatment is still available …

Alzheimer's disease (AD), considered a common type of dementia, is mainly characterized
by a progressive loss of memory and cognitive functions. Although its cause is multifactorial …

Purpose Developing a sensitive SERS-based method to quantitatively detect serum
biomarkers (Aβ1-42 and P-Tau-181) for the early diagnosis of Alzheimer's disease (AD) …

Alzheimer's disease (AD) is the fifth leading cause of death on the planet. It hallmarks the
presence of amyloid plaques and neurofibrillary tangles in geriatric patients. The condition …

Alzheimer's Disease (AD) is an irreversible neurodegenerative disease for which no
modifying therapies are presently available. Besides the identification of pathological …

Recently, the aging population has increased exponentially around the globe bringing more
challenges to improve quality of life in those populations while reducing the economic …

Amyloid plaques generated from the accumulation of amyloid-β peptides (Aβ) fibrils in the
brain is one of the main hallmarks of Alzheimer's disease (AD), a most common …

Among central nervous system (CNS) disorders, Alzheimer's disease (AD) is the most
prevalent neurodegenerative disorder and a major cause of dementia worldwide. The yet …